GLASS I n = 27 (%) | GLASS II n = 31 (%) | GLASS III n = 9 (%) | p** | |
---|---|---|---|---|
ABI after intervention | 0.7 ± 0.17 | 0.58 ± 0.14 | 0.61 ± 0.16 | 0.016*** |
Increase in ABI | 0.26 ± 0.1 | 0.29 ± 0.16 | 0.38 ± 0.12 | 0.71*** |
ABI increase ≥ 0.15 (Number of cases) | 26 (96.3%) | 30 (96.77%) | 7 (77.78%) | 0.086* |
ABI after 6 months | 0.68 ± 0.26 | 0.55 ± 0.17 | 0.49 ± 0.19 | 0.025*** |
ABI after 12 months | 0.64 ± 0.22 | 0.5 ± 0.25 | 0.47 ± 0.13 | 0.037*** |
Maintenance of perfusion of the TAP after 6 months (Number of cases) | 27 (100) | 25 (80.65) | 5 (55.56) | 0.003* |
Maintenance of perfusion of the TAP after 12 months (Number of cases) | 24 (88.89) | 21 (67.74) | 2 (22.22) | 0.001* |